Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

NCT05379946 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: D-1553
DRUG: IN10018

Sponsor

InventisBio Co., Ltd

Collaborators

[object Object]